Search
Understanding Stigma and Cognitive Behavioural Interpersonal Skills- PAHO's online self-learning and tutor-guided course
The Pan-American Health Organization (PAHO), jointly with the Mental Health Commission of Canada, will hold a new online self-learning and tutor-guided course "Understanding Stigma and Cognitive Behavioral Interpersonal Skills" from August...
Review of a decade of drug policy: Progress and Challenges
Introduction According to the latest World Drug Report published by the United Nations Office on Drugs and Crime (UNODC) for the year 2022, around 284 million people between the ages of 15 and 64 used drugs.
WHO stakeholder survey on improving access to morphine for medical use
WHO launched a survey on assessing barriers, enablers, and pirority actions for improving access to morphine for medical use.
All Civil Society Organisation can contribute by filling out the survey before 31 August 2022.
The survey...
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
Background
In the United States, access to buprenorphine remains low and disparities regarding who receives treatment have emerged. Federal laws have regulated buprenorphine delivery, ultimately limiting its implementation more broadly...
The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis
Background
Beginning in the 1990s, non-medical use of prescription opioids (POs) became a major public health crisis. In response to rising rates of opioid dependence and fatal poisonings, measures were instituted to decrease the...
Addressing drug challenges in health and humanitarian crises: Settings in need of care for a comprehensive drug use prevention in Nigeria
Paper presented at the commemoration of the 2022 International Day Against Drug Abuse & Illicit Trafficking, State House Conference Centre, Abuja, Nigeria.
Bi-Monthly Webinar: ISSUP Nigeria Knowledge Update Series (Thirteenth Session)
ISSUP Nigeria would like to invite you to attend their next Bi-Monthly Webinar in the Knowledge Update Series. The Webinar topic will be Beyond Dependence: Alcohol-induced Disorders.
Learning Outcomes:
• Sensitization to the wide...
Treating co-occurring substance use and mental health disorders using tools from CBT
Presented by Jo Cassar (The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney), by the end of this webinar, attendees will be able to:
- Recognise the importance of assessing for substance use when a...
Eating disorders and AOD use: what clinicians need to know
Presented by Associate Professor Sarah Maguire (Director, InsideOut Institute), by attending this webinar, attendees will learn:
- How to recognise the most common eating disorder symptoms;
- Eating disorder interventions and how...
Kenya to include smoking cessation drugs as essential medicines
The Ministry of Health has been advised to add two non-nicotine drugs to Kenya’s Essential Medicines List, to help smokers quit tobacco and nicotine addiction.
The World Health Organization said the two drugs bring “a powerful shift in...
Multiple disadvantage and co-occurring substance use and mental health conditions.
Substance use and mental health needs are two of the primary concerns for many people experiencing multiple disadvantage. We know that people who experience both issues at the same time (also known as “co-occurring conditions” or “dual...
The impact of discrimination on substance use disorders among sexual minorities
This paper aimed to review the literature regarding the impact of discrimination on substance use disorders among Sexual Minorities, with a focus on alcohol, opioids, stimulants, polydrug use, chemsex, cannabis and tobacco, as well as...
The cardiovascular risks and benefits of quit smoking medicines
In this presentation, the speakers reported the results of a series of three population-based cohort studies relating to the use and effects of smoking cessation pharmacotherapies. The first of these studies provided evidence on how the...
Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth
Abstract
Importance Prenatal smoking is a known modifiable risk factor for stillbirth; however, the contribution of prenatal drinking or the combination of smoking and drinking is uncertain.
Objective To examine whether prenatal...
Accreditation of Study Programs on Addictions in Nigerian Universities: Challenges, Opportunities, and the Need for Advocacy
INTRODUCTION:
Access to drug treatment services in Nigeria remains low due to a severe shortage in the drug treatment workforce. Plans are underway to address the workforce shortage by introducing drug addiction training programs in...
AddictologyIssue 1/2022
New Psychoactive Substances (NPS) Webinar Series
Various NPS have significantly changed the picture of drug use in different countries. They are now very prominent in the drug market. Indeed, many of these substances are intended to circumvent drug laws and are sold as ‘legal’...
The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis
Comorbid mental illnesses and substance use disorders are associated with adverse criminal, social, and health outcomes. Yet, their burden is not reliably known among prison populations. We therefore aimed to estimate the prevalence of comorbid serious mental illnesses and substance use disorders (dual disorders) among people in prison worldwide.
New Psychoactive Substances: Reading List
New psychoactive substances (NPS) are a diverse group of substances designed to replicate the effects of substances like cannabis, cocaine and ecstasy.
Project NEPTUNE training modules
In partnership with the Royal College of Psychiatrists, Project NEPTUNE has developed training modules to improve clinical practice in the management of harms resulting from the use of club drugs and novel psychoactive substances.
These...
Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances
This document provides guidance on the clinical management of harms resulting from acute intoxication and from the harmful and dependent use of club drugs and Novel Psychoactive Substances (NPS).
This is an extensive and comprehensive...